"Intraoperative pillar corticosteroid injection": does it improve clinical outcomes after carpal tunnel release surgery? A double-blind, randomized controlled study

“术中柱状皮质类固醇注射”:能否改善腕管松解术后的临床疗效?一项双盲随机对照研究

阅读:1

Abstract

The purpose of this study was to assess the therapeutic effects of intraoperative direct pillar corticosteroid injection in patients with carpal tunnel syndrome(CTS) who underwent open carpal tunnel release (OCTR) surgery. A prospective randomized controlled trial was conducted on 62 patients with carpal tunnel syndrome. Two intraoperative pillar injection solutions were compared: the lidocaine with triamcinolone acetonide and the lidocaine alone. Injections were administered at two points each at the scaphoid and trapezium bones in the radial pillar area, and at the hamate and pisiform bones in the ulna pillar area. Post-operatively, there were no significant differences in patient satisfaction, functional outcomes and pillar pain between the groups. Notably, the resolution time for pillar pain was prolonged in the steroid group. Conclusion Intraoperative corticosteroid pillar injection is not an effective option for preventing pillar pain symptoms. Level of evidence Level I.Trial registration The trial was registered in the Thai Clinical Trials Registry (TCTR) database. The identification number is TCTR20211130003, date of registration 30/11/2021.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。